Correlation Between Swiss Leader and Newron Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Swiss Leader and Newron Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Swiss Leader and Newron Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Swiss Leader Price and Newron Pharmaceuticals SpA, you can compare the effects of market volatilities on Swiss Leader and Newron Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Swiss Leader with a short position of Newron Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Swiss Leader and Newron Pharmaceuticals.
Diversification Opportunities for Swiss Leader and Newron Pharmaceuticals
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Swiss and Newron is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Swiss Leader Price and Newron Pharmaceuticals SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Newron Pharmaceuticals and Swiss Leader is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Swiss Leader Price are associated (or correlated) with Newron Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Newron Pharmaceuticals has no effect on the direction of Swiss Leader i.e., Swiss Leader and Newron Pharmaceuticals go up and down completely randomly.
Pair Corralation between Swiss Leader and Newron Pharmaceuticals
Assuming the 90 days trading horizon Swiss Leader Price is expected to generate 0.3 times more return on investment than Newron Pharmaceuticals. However, Swiss Leader Price is 3.37 times less risky than Newron Pharmaceuticals. It trades about 0.03 of its potential returns per unit of risk. Newron Pharmaceuticals SpA is currently generating about -0.05 per unit of risk. If you would invest 192,731 in Swiss Leader Price on September 1, 2024 and sell it today you would earn a total of 1,024 from holding Swiss Leader Price or generate 0.53% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Swiss Leader Price vs. Newron Pharmaceuticals SpA
Performance |
| Timeline |
Swiss Leader and Newron Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Swiss Leader Price
Pair trading matchups for Swiss Leader
Newron Pharmaceuticals SpA
Pair trading matchups for Newron Pharmaceuticals
Pair Trading with Swiss Leader and Newron Pharmaceuticals
The main advantage of trading using opposite Swiss Leader and Newron Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Swiss Leader position performs unexpectedly, Newron Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Newron Pharmaceuticals will offset losses from the drop in Newron Pharmaceuticals' long position.| Swiss Leader vs. Graubuendner Kantonalbank | Swiss Leader vs. Thurgauer Kantonalbank | Swiss Leader vs. mobilezone ag | Swiss Leader vs. Zurich Insurance Group |
| Newron Pharmaceuticals vs. Santhera Pharmaceuticals Holding | Newron Pharmaceuticals vs. Basilea Pharmaceutica AG | Newron Pharmaceuticals vs. Addex Therapeutics | Newron Pharmaceuticals vs. Evolva Holding SA |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |